Abstract
(Abstracted from Acta Obstet Gynecol Scand 2021;100:1779–1787) Heavy menstrual bleeding (HMB) affects approximately 10% to 30% of women of reproductive age and is often treated conservatively with insertion of a levonorgestrel-releasing intrauterine system (LNG-IUS) or endometrial ablation/resection (EA). The LNG-IUS induces atrophy of endometrial tissue, whereas EA is a minimally invasive, uterus-preserving procedure that destroys endometrial tissue and superficial myometrium.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
